Providencia sp.: Difference between revisions
(Created page with "==Background== ==Antibiotic Sensitivities<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== {| class="wikitable" ===Key=== {{Template:Antibacterial Spectra Key}} ...") |
|||
| Line 3: | Line 3: | ||
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== | ||
{| class="wikitable" | {| class="wikitable" | ||
| align="center" style="background:#f0f0f0;"|'''Category''' | |||
| align="center" style="background:#f0f0f0;"|'''Antibiotic''' | |||
| align="center" style="background:#f0f0f0;"|'''Sensitivity''' | |||
|- | |||
| [[Penicillins]]||[[Penicillin G]]||R | |||
|- | |||
| ||[[Penicillin V]]||R | |||
|- | |||
| Anti-Staphylocccal [[Penicillins]]||[[Methicillin]]||R | |||
|- | |||
| ||[[Nafcillin]]/[[Oxacillin]]||R | |||
|- | |||
| ||[[Cloxacillin]]/[[Diclox.]]||R | |||
|- | |||
| Amino-[[Penicillins]]||[[AMP]]/[[Amox]]||R | |||
|- | |||
| ||[[Amox-Clav]]||'''S''' | |||
|- | |||
| ||[[AMP-Sulb]]||'''S''' | |||
|- | |||
| Anti-Pseudomonal [[Penicillins]]||[[Ticarcillin]]||'''S''' | |||
|- | |||
| ||[[Ticar-Clav]]||'''S''' | |||
|- | |||
| ||[[Pip-Tazo]]||'''S''' | |||
|- | |||
| ||[[Piperacillin]]||'''S''' | |||
|- | |||
| [[Carbapenems]]||[[Doripenem]]||'''S''' | |||
|- | |||
| ||[[Ertapenem]]||'''S''' | |||
|- | |||
| ||[[Imipenem]]||'''S''' | |||
|- | |||
| ||[[Meropenem]]||'''S''' | |||
|- | |||
| ||[[Aztreonam]]||'''S''' | |||
|- | |||
| [[Fluroquinolones]]||[[Ciprofloxacin]]||'''S''' | |||
|- | |||
| ||[[Ofloxacin]]||'''S''' | |||
|- | |||
| ||[[Pefloxacin]]||'''S''' | |||
|- | |||
| ||[[Levofloxacin]]||'''S''' | |||
|- | |||
| ||[[Moxifloxacin]]||'''S''' | |||
|- | |||
| ||[[Gemifloxacin]]||X1 | |||
|- | |||
| ||[[Gatifloxacin]]||'''S''' | |||
|- | |||
| 1st G [[Cephalo]]||[[Cefazolin]]||R | |||
|- | |||
| 2nd G. [[Cephalo]]||[[Cefotetan]]||'''S''' | |||
|- | |||
| ||[[Cefoxitin]]||'''S''' | |||
|- | |||
| ||[[Cefuroxime]]||R | |||
|- | |||
| 3rd/4th G. [[Cephalo]]||[[Cefotaxime]]||'''S''' | |||
|- | |||
| ||[[Cefizoxime]]||'''S''' | |||
|- | |||
| ||[[CefTRIAXone]]||'''S''' | |||
|- | |||
| ||[[Ceftaroline]]||'''S''' | |||
|- | |||
| ||[[CefTAZidime]]||'''S''' | |||
|- | |||
| ||[[Cefepime]]||'''S''' | |||
|- | |||
| Oral 1st G. [[Cephalo]]||[[Cefadroxil]]||R | |||
|- | |||
| ||[[Cephalexin]]||R | |||
|- | |||
| Oral 2nd G. [[Cephalo]]||[[Cefaclor]]/[[Loracarbef]]||R | |||
|- | |||
| ||[[Cefproxil]]||R | |||
|- | |||
| ||[[Cefuroxime axetil]]||'''S''' | |||
|- | |||
| Oral 3rd G. [[Cephalo]]||[[Cefixime]]||'''S''' | |||
|- | |||
| ||[[Ceftibuten]]||'''S''' | |||
|- | |||
| ||[[Cefpodox]]/[[Cefdinir]]/[[Cefditoren]]||X1 | |||
|- | |||
| [[Aminoglycosides]]||[[Gentamicin]]||X1 | |||
|- | |||
| ||[[Tobramycin]]||X1 | |||
|- | |||
| ||[[Amikacin]]||X1 | |||
|- | |||
| ||[[Chloramphenicol]]||X1 | |||
|- | |||
| ||[[Clindamycin]]||X1 | |||
|- | |||
| [[Macrolides]]||[[Erythromycin]]||X1 | |||
|- | |||
| ||[[Azithromycin]]||X1 | |||
|- | |||
| ||[[Clarithromycin]]||X1 | |||
|- | |||
| Ketolide||[[Telithromycin]]||X1 | |||
|- | |||
| Tetracyclines||[[Doxycycline]]||X1 | |||
|- | |||
| ||[[Minocycline]]||X1 | |||
|- | |||
| Glycylcycline||[[Tigecycline]]||X1 | |||
|- | |||
| ||[[Daptomycin]]||X1 | |||
|- | |||
| Glyco/Lipoclycopeptides||[[Vancomycin]]||X1 | |||
|- | |||
| ||[[Teicoplanin]]||X1 | |||
|- | |||
| ||[[Telavancin]]||X1 | |||
|- | |||
| ||[[Fusidic Acid]]||X1 | |||
|- | |||
| ||[[Trimethoprim]]||X1 | |||
|- | |||
| ||[[TMP-SMX]]||X1 | |||
|- | |||
| Urinary Agents||[[Nitrofurantoin]]||X1 | |||
|- | |||
| ||[[Fosfomycin]]||X1 | |||
|- | |||
| Other||[[Rifampin]]||X1 | |||
|- | |||
| ||[[Metronidazole]]||X1 | |||
|- | |||
| ||[[Quinupristin dalfoppristin]]||X1 | |||
|- | |||
| ||[[Linezolid]]||X1 | |||
|- | |||
| ||[[Colistimethate]]||X1 | |||
|} | |||
===Key=== | ===Key=== | ||
Latest revision as of 02:09, 24 June 2014
Background
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014
